Ahmed Bahi on Lina Merghani’s Critique of Early Withdrawal of Aspirin after PCI
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News in Cardiovascular Research!
I’m thrilled to share that I recently had the opportunity to supervise my pharmD student Lina Merghani in critique of a groundbreaking study published in NEJM focused on the ”early withdrawal of aspirin after percutaneous coronary intervention (PCI) in acute acute coronary syndrome (ACS)”..
In my critique, Dr Lina highlighted benefit vs risk of stopping aspiring after acute ACS.
I want to commend our PharmD student for their hard work and dedication to advancing care for trauma patients.
Your contributions are paving the way for improved patient outcomes.
Let’s continue to push the boundaries of knowledge and improve the lives of our patients.”
Read the full article in NEJM.
Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
Authors: NEO-MINDSET Trial Investigators
Stay updated with Hemostasis Today.
-
Dec 7, 2025, 17:01Abdul Mannan: How Do You Manage a Major Surgery When Blood Transfusion is Impossible?
-
Dec 7, 2025, 16:30Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study
-
Dec 7, 2025, 16:21Jonathan Douxfils: Can We Estimate the VTE Risk of a Pill Before a Million Women Use It?
-
Dec 7, 2025, 16:06Pablo Corral on Why Early LDL-C Reduction Saves Lives
-
Dec 7, 2025, 15:53Paul Batty Congratulates Giulia Simini on Taking The Joint BSH-ASH Abstract Award
-
Dec 7, 2025, 15:35Federica Fogacci Presents The New ILEP Consensus Paper
-
Dec 7, 2025, 15:20Deep Molecular Modeling for Type 2A VWD from Omid Seidizadeh
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed